Manufacturers Life Insurance Company »

Inhibikase Therapeutics shares owned by Manufacturers Life Insurance Company

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Manufacturers Life Insurance Company from 13F filings

Historical chart of Manufacturers Life Insurance Company investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Manufacturers Life Insurance Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Manufacturers Life Insurance Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 29k 1.68

More positions owned by Manufacturers Life Insurance Company

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
John Hancock Exchange Traded Core Bond Etf (JHCR)
Rbc Cad (RY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Toronto Dominion Bk Ont Com New (TD)
Eli Lilly & Co. (LLY)
Canadian Natural Resources (CNQ)
Cheniere Energy Com New (LNG)
Shopify Cl A Sub Vtg Shs (SHOP)
Suncor Energy (SU)

View all positions for Manufacturers Life Insurance Company

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Trails Edge Capital Partners
ADAR1 Capital Management
BlackRock
Blackstone Group
Siren
Commodore Capital
Vanguard Group
Vanguard Capital Management
Saturn V Capital Management
Kalehua Capital Management
Squadron Capital Management
Millennium Management

View all funds holding Inhibikase Therapeutics